XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

Business and Geographical Reporting Segments (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Business and Geographical Reporting Segments [Abstract] |
Segment Reporting Information by Segment | The following tables present results of operations from the Company’s business segments for the periods indicated below (in thousands, except gross profit %):
Three Months Ended March 31, 2025 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Revenues, net |  | $ | 4,727 |  |  | $ | 2,085 |  |  | $ | 6,812 |
Cost of revenues |  |  | 2,049 |  |  |  | 1,116 |  |  |  | 3,165 |
Gross profit |  |  | 2,678 |  |  |  | 969 |  |  |  | 3,647 |
Gross profit % |  |  | 56.7 | % |  |  | 46.5 | % |  |  | 53.5 | %
Allocated expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 66 |  |  |  | 30 |  |  |  | 96 |
Selling and marketing |  |  | 2,077 |  |  |  | 916 |  |  |  | 2,993 |
Unallocated expenses |  |  | — |  |  |  | — |  |  |  | 2,573 |
Total allocated and unallocated expenses |  |  | 2,143 |  |  |  | 946 |  |  |  | 5,662 |
Income (loss) from operations |  |  | 535 |  |  |  | 23 |  |  |  | (2,015 | )
Interest expense |  |  | — |  |  |  | — |  |  |  | (486 | )
Interest income |  |  | — |  |  |  | — |  |  |  | 69 |
Net income (loss) |  | $ | 535 |  |  | $ | 23 |  |  | $ | (2,432 | )
Three Months Ended March 31, 2024 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Revenues, net |  | $ | 4,696 |  |  | $ | 2,058 |  |  | $ | 6,754 |
Cost of revenues |  |  | 2,195 |  |  |  | 1,479 |  |  |  | 3,674 |
Gross profit |  |  | 2,501 |  |  |  | 579 |  |  |  | 3,080 |
Gross profit % |  |  | 53.3 | % |  |  | 28.1 | % |  |  | 45.6 | %
Allocated expenses: |  |  |  |  |  |  |  |  |  |  |  |
Engineering and product development |  |  | 196 |  |  |  | 45 |  |  |  | 241 |
Selling and marketing |  |  | 2,753 |  |  |  | 265 |  |  |  | 3,018 |
Unallocated expenses |  |  | — |  |  |  | — |  |  |  | 2,710 |
Total allocated and unallocated expenses |  |  | 2,949 |  |  |  | 310 |  |  |  | 5,969 |
(Loss) income from operations |  |  | (448 | ) |  |  | 269 |  |  |  | (2,889 | )
Interest expense |  |  | — |  |  |  | — |  |  |  | (524 | )
Interest income |  |  | — |  |  |  | — |  |  |  | 45 |
Net (loss) income |  | $ | (448 | ) |  | $ | 269 |  |  | $ | (3,368 | )
Depreciation and Amortization by Reportable Segment | The following table presents depreciation and amortization by reportable segment for the periods indicated below (in thousands):
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
Dermatology recurring procedures |  | $ | 1,120 |  |  | $ | 1,114 |
Dermatology procedures equipment |  |  | 100 |  |  |  | 132 |
Unallocated expenses |  |  | — |  |  |  | 3 |
Total |  | $ | 1,220 |  |  | $ | 1,249 |
Disaggregation of Revenue by Geographical Region | The following tables present the Company’s revenue disaggregated by geographical region for the periods indicated below (in thousands). Domestic refers to revenue from customers based in the United States, and foreign revenue is derived from the Company’s distributors primarily in Asia.
Three Months Ended March 31, 2025 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Domestic |  | $ | 4,248 |  |  | $ | 149 |  |  | $ | 4,397 |
China |  |  | — |  |  |  | 834 |  |  |  | 834 |
Middle East |  |  | — |  |  |  | 711 |  |  |  | 711 |
Other foreign |  |  | 479 |  |  |  | 391 |  |  |  | 870 |
Total |  | $ | 4,727 |  |  | $ | 2,085 |  |  | $ | 6,812 |
Three Months Ended March 31, 2024 |  | Dermatology Recurring Procedures |  |  | Dermatology Procedures Equipment |  |  | Total |
Domestic |  | $ | 4,320 |  |  | $ | 141 |  |  | $ | 4,461 |
China |  |  | — |  |  |  | 1,102 |  |  |  | 1,102 |
Middle East |  |  | — |  |  |  | 430 |  |  |  | 430 |
Other foreign |  |  | 376 |  |  |  | 385 |  |  |  | 761 |
Total |  | $ | 4,696 |  |  | $ | 2,058 |  |  | $ | 6,754 |
Total Assets by Reportable Segment | The following table presents total assets by reportable segment (in thousands):
|  | March 31, 2025 |  |  | December 31, 2024 |
Dermatology recurring procedures |  | $ | 20,071 |  |  | $ | 21,750 |
Dermatology procedures equipment |  |  | 5,798 |  |  |  | 5,081 |
Other unallocated assets |  |  | 8,393 |  |  |  | 9,326 |
Total |  | $ | 34,262 |  |  | $ | 36,157 |

X
- Definition Tabular disclosure of depreciation and amortization expense for each reportable segment. + References No definition available. + Details
Name: | sskn_DepreciationAndAmortizationByReportableSegmentTableTextBlock
Namespace Prefix: | sskn_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration